$67.520
+0.770 (+1.14%)終値時点
MC のニュース
MC のイベント
Company Reports Q2 Revenue of $409.4M
Reports Q2 revenue $409.4M, consensus $388.69M. "Our record second-quarter and first-half revenues reflect the depth of our client franchise and the continued expansion of our advisory capabilities. We are seeing strong client engagement and momentum in transaction activity, and we are well positioned to deliver exceptional outcomes for our clients while creating long-term value for our shareholders," said Navid Mahmoodzadegan, Chief Executive Officer and Co-Founder.
Strategy in Talks with Moelis for Preferred Share Exchange
Distressed-debt funds that snapped up Strategy's (MSTR) beaten-down preferred shares are in talks with Moelis (MC) about exchanging their holdings for other preferred shares at a discounted price, or potentially for common shares, people familiar with the matter told Bloomberg's Reshmi Basu. Such a potential swap is being pitched as "a win-win as the relentless rout in crypto puts the Bitcoin accumulator in an increasingly tough spot," the report stated.
Moelis Files to Sell Class A Common Stock
Moelis files to sell Class A common stock, no amount given
Company Reports Q1 Revenue of $319.8M
Reports Q1 revenue $319.8M, consensus $322.8M. "We reported record first quarter revenues and advised our clients on a record level of first quarter announced transaction activity. With our pipeline near all-time highs, our Firm is positioned for continued strong performance. We remain focused on delivering for our clients, investing in our people, and generating long-term value for our shareholders," said Navid Mahmoodzadegan, Chief Executive Officer and Co-Founder.
Qiagen Explores Strategic Alternatives with Moelis and Goldman
At the TD Cowen 46th Annual Health Care Conference, Qiagen (QGEN) CEO Thierry Bernard disclosed that the company is working with Moelis (MC) and Goldman (GS) to explore strategic alternatives. "We are convinced that having strategic alternative reviews is good for our shareholders," Qiagen said.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。